The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Isatuximab plus pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: Subgroup analysis by prior anti-CD38 exposure from the phase 3 IRAKLIA trial.
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Marek Hus
Honoraria - Abbvie; AstraZeneca; GlaxoSmithKline; Janssen; Sanofi; SOBI
Consulting or Advisory Role - AstraZeneca; Janssen; Novartis; SOBI
 
Raimundo Gazitua
Stock and Other Ownership Interests - Lilly; Novo Nordisk
Consulting or Advisory Role - Abbvie; Roche
Speakers' Bureau - Abbvie; Astellas Pharma; Roche; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Johnson & Johnson/Janssen; Roche
 
Aijun Liao
No Relationships to Disclose
 
Wojciech Janowski
Consulting or Advisory Role - AstraZeneca; Janssen
Speakers' Bureau - BeiGene
 
Cindy Lee
No Relationships to Disclose
 
Gabor Mikala
No Relationships to Disclose
 
Artur Jurczyszyn
No Relationships to Disclose
 
Alejandro Berkovits
Speakers' Bureau - Johnson & Johnson/Janssen; Novartis; Pfizer
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Janssen (Inst)
 
Jin Lu
No Relationships to Disclose
 
Fredrik Schjesvold
Honoraria - Abbvie; Amgen; BMSi; GlaxoSmithKline; Johnson & Johnson/Janssen; Menarini; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - BMSi; Caedo therapeutics; Galapagos NV; GlaxoSmithKline; Johnson & Johnson/Janssen; Oncopeptides; Pfizer; Regeneron; Sanofi; Takeda; XNK therapeutics
Research Funding - Circio
Expert Testimony - GlaxoSmithKline
 
Silvia Ling
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - BMS
 
Andrew Spencer
Honoraria - Antengene; BMS; Genentech/Roche; Janssen-Cilag; Pfizer; Thermofisher Scientific Biomarkers
Consulting or Advisory Role - Antengene; Celltrion; GlaxoSmithKline; Haemalogix; Janssen-Cilag; Pfizer; Rheumagen
Speakers' Bureau - Janssen-Cilag; Pfizer; Thermofisher Scientific Biomarkers
Research Funding - Antengene; BMS; Janssen-Cilag; Sanofi
 
Sikander Ailawadhi
Consulting or Advisory Role - Arcellx; Ascentage Pharma (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pfizer; Regeneron; Sanofi
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Cellectar (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Sanofi (Inst)
 
Tondre Buck
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
 
Umer Khan
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Florence Suzan
Employment - Sanofi/Aventis
Stock and Other Ownership Interests - Sanofi/Aventis
 
Maya Stefanova-Urena
No Relationships to Disclose
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Johnson&Johnson; Pfizer; Regeneron; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Ivan Špicka
Consulting or Advisory Role - BMS GmbH & Co. KG; Janssen-Cilag; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Janssen-Cilag; Sanofi
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi